BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31782605)

  • 1. Blastic plasmacytoid dendritic cell neoplasm with t(2;8)(p12;q24).
    Seiwell AP; Buckley K; Pettenati M; Grier DD
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28097. PubMed ID: 31782605
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocation.
    Nakamura Y; Kayano H; Kakegawa E; Miyazaki H; Nagai T; Uchida Y; Ito Y; Wakimoto N; Mori S; Bessho M
    Blood Cancer J; 2015 Apr; 5(4):e301. PubMed ID: 25860292
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated blastic plasmacytoid dendritic cell neoplasm.
    Loghavi S; Khoury JD
    Blood; 2015 Jul; 126(4):558. PubMed ID: 26421330
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
    Sapienza MR; Fuligni F; Melle F; Tabanelli V; Indio V; Laginestra MA; Motta G; Mazzara S; Cerroni L; Pileri A; Facchetti F; Paulli M; Cascione L; Laganà A; Berti E; Ferracin M; Agostinelli C; Sabattini E; Croce CM; Pileri SA
    Hematol Oncol; 2020 Dec; 38(5):831-833. PubMed ID: 33405278
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
    Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
    Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distinctive cytology and disease evolution of blastic plasmacytoid dendritic cell neoplasm.
    Fernandes F; Barreira R; Cortez J; Silveira M; Bain BJ
    Am J Hematol; 2018 Nov; 93(11):1431-1432. PubMed ID: 30020546
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
    Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
    Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
    Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
    Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.
    Sumarriva Lezama L; Chisholm KM; Carneal E; Nagy A; Cascio MJ; Yan J; Chang CC; Cherry A; George TI; Ohgami RS
    Histopathology; 2018 Nov; 73(5):767-776. PubMed ID: 29884995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of disseminated blastic plasmocytoid dendritic cell neoplasm.
    Loscocco GG; Piccini M; Vergoni F; Vannucchi AM; Bosi A
    Am J Hematol; 2018 Nov; 93(11):1433-1434. PubMed ID: 29664121
    [No Abstract]   [Full Text] [Related]  

  • 11. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
    Kubota S; Tokunaga K; Umezu T; Yokomizo-Nakano T; Sun Y; Oshima M; Tan KT; Yang H; Kanai A; Iwanaga E; Asou N; Maeda T; Nakagata N; Iwama A; Ohyashiki K; Osato M; Sashida G
    Nat Commun; 2019 Apr; 10(1):1653. PubMed ID: 30971697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.
    Kurt H; Khoury JD; Medeiros LJ; Huh YO
    Br J Haematol; 2018 May; 181(3):305. PubMed ID: 29411884
    [No Abstract]   [Full Text] [Related]  

  • 13. Blastic plasmacytoid dendritic cell neoplasm with unusual lymphoid features and macrovacuoles.
    Lyapichev KA; Sukswai N; Konoplev S; Khoury JD
    Ann Hematol; 2019 Sep; 98(9):2221-2222. PubMed ID: 30955062
    [No Abstract]   [Full Text] [Related]  

  • 14. Blastic Plasmocytoid Dendritic Cell Neoplasm With Skin and Myeloid Location.
    Mizia-Malarz A; Sobol-Milejska G
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e29-e31. PubMed ID: 28060117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastic Plasmacytoid Dendritic Cell Neoplasm: First Case Report From Rwanda and Review of the Literature.
    Ruhangaza D; Mugabe MC; Kigonya CN; Lane AA; Morgan EA
    J Glob Oncol; 2019 Jun; 5():1-6. PubMed ID: 31246550
    [No Abstract]   [Full Text] [Related]  

  • 16. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms.
    Boddu PC; Wang SA; Pemmaraju N; Tang Z; Hu S; Li S; Xu J; Medeiros LJ; Tang G
    Leuk Res; 2018 Mar; 66():73-78. PubMed ID: 29407586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation (2;8)(p12;q24) associated with a cryptic t(12;21)(p13;q22) TEL/AML1 gene rearrangement in a child with acute lymphoblastic leukemia.
    Loh ML; Samson Y; Motte E; Moreau LA; Dalton V; Waters S; Sallan SE; Gilliland DG
    Cancer Genet Cytogenet; 2000 Oct; 122(2):79-82. PubMed ID: 11106815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
    Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
    Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.
    De Jong D; Voetdijk BM; Beverstock GC; van Ommen GJ; Willemze R; Kluin PM
    N Engl J Med; 1988 May; 318(21):1373-8. PubMed ID: 3285208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.